Interobiosystems

2 known investors

Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.

BiotechDeep TechHealthtech